跳至主要内容
临床试验/CTRI/2010/091/001046
CTRI/2010/091/001046已完成3 期

An open labeled, randomized, comparative study to evaluate the Efficacy and Safety of Etimicin Sulphate v/s Amikacin in patients suffering from various bacterial infections

Venus Remedies Limited6 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2010年6月7日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200
试验地点
6
主要终点
To evaluate the Efficacy of Etimicin Sulphate vs Amikacin in patients suffering from various bacterial infections

研究概览

简要总结

This an open labeled, randomized, comparative study to evaluate efficacy and safety of test drug (Etimicin Sulphate) vs Amikacin sulphate. A total of 200 patients which lies in the age group of 18 to 60 years and are suffering from various bacterial infections will be enrolled at this multi centric two arm comparative phase-3 trial. In arm A 100 patients will be treated with Etimicin 4.5mg/kg/day while another 100 patients (Arm B) will receive treatment of Amikacin 15 mg/kg/day divided into 2 or 3 equal doses administered at equally-divided intervals. The primary objective is to establish the efficacy of test drugs , while secondary objectives of the study is to confirm the safety of both the drugs.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Male and female subjects in the age group of above 18 years till 60 years shall be selected.
  • Presence of an abnormal chest x-ray (CXR) as determined by the primary care team in case of LRTI patients Clinically diagnosed subjects with Respiratory tract infections mainly LRTI (Lower respiratory tract infections) , skin & skin structure infections, UTI (Urinary tract infections), surgical infections Patients or legal guardian or LAR (Legally acceptable representative) ready to give written informed consent.

排除标准

  • History of hypersensitivity reaction or any specific contraindication to Aminoglycosides or Etimicin or AmikacinPresence of hepatic or renal disordersHistory of hearing lossPregnant or lactating women.

结局指标

主要结局

To evaluate the Efficacy of Etimicin Sulphate vs Amikacin in patients suffering from various bacterial infections

时间窗: nil

次要结局

  • To evaluate the Safety and tolerability of Etimicin Sulphate vs Amikacin in patients suffering from various bacterial infections

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (6)

Loading locations...

相似试验